News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Invitation to Q2 2008 Conference Call of MorphoSys AG On July 29, 2008
July 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MARTINSRIED, Germany, July 23, 2008 (PRIME NEWSWIRE) -- MorphoSys AG (FSE:MOR) (Prime Standard Segment, TecDAX) will publish its first six months' 2008 results on July 29, 2008 at 7:30 a.m. CEST.
Twitter
LinkedIn
Facebook
Email
Print
Events
Europe
MORE ON THIS TOPIC
Insights
The Italian inflection point: Clinical strength, culture and capital
August 13, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Insights
Austria’s new growth fund could further bolster its dynamic biotech innovation economy
August 11, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Insights
Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity
August 3, 2026
·
2 min read
·
Jennifer C. Smith-Parker
FDA
Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
August 3, 2026
·
9 min read
·
Jef Akst